MYOS Issues Special Letter to Shareholders: Company Committed to R&D, Developing Innovative Products and Formulations
06. August 2012 07:55 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Aug 6, 2012) - MYOS Corporation's (OTCBB: MYOS) Board of Directors today issued the following Letter to Shareholders:
Dear Shareholder:
Your MYOS...
MYOS Announces $5.6 Million Equity Private Placement
02. Juli 2012 08:59 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Jul 2, 2012) - MYOS Corporation (OTCBB: MYOS) (the "Company") today announced that it has entered into agreements with various institutions, accredited investors and...
MYOS Names Veteran Biotechnology Executive Dr. Sol J. Barer to Chair Scientific Advisory Board
27. Juni 2012 07:55 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Jun 27, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...
MYOS Appoints Astronaut Buzz Aldrin to Its Board of Directors
31. Mai 2012 08:25 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - May 31, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...
MYOS Signs Distribution Deal, Sees Year One Sales Exceeding $5 Million
22. Mai 2012 08:29 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - May 22, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...
Atlas Therapeutics Changes Its Name and Ticker Symbol to MYOS Corporation and "MYOS"; Launches New Corporate Website
21. Mai 2012 06:55 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - May 21, 2012) - Atlas Therapeutics Corporation (OTCBB: ATTH) (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health...